A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1998
12/16/1998	EP0884321A1 Ascorbic acid 2-phosphate zinc salt and process for manufacturing the same
12/16/1998	EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998	EP0884056A1 Vaccines containing a saponin and a sterol
12/16/1998	EP0883993A1 Antiviral materials
12/16/1998	EP0883688A1 Adapter molecules for targeting viral particles to cells
12/16/1998	EP0883621A1 Cephalosporin derivatives and processes for the preparation thereof
12/16/1998	EP0883344A1 Therapeutic molecules generated by trans-splicing
12/16/1998	EP0762878B1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
12/16/1998	EP0575553B1 Recombinant hybrid porin epitopes
12/16/1998	EP0454781B1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
12/16/1998	CN1201692A Vaccine
12/16/1998	CN1201687A Shennong powder for Hong Kong foot and preparation thereof
12/16/1998	CN1201684A Capsule of ginkgo and garlic extracts
12/16/1998	CN1041204C Pentacyclic triterpenoid compound as toposomerase inhibitors or cell differentiation inducers
12/16/1998	CN1041202C Quinolone carboxylic acid derivative
12/16/1998	CN1041166C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in obtaining of antiulcer, complexes and chelates
12/15/1998	US5849896 α-subunit of the Mac-1 leukocyte adhesion receptor
12/15/1998	US5849893 Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics
12/15/1998	US5849883 Method for purifying granulocyte colony stimulating factor
12/15/1998	US5849803 Method of treating erectile dysfunction with nitroglycerine
12/15/1998	US5849800 Use of amantadine for treatment of Hepatitis C
12/15/1998	US5849797 D-β-lysylmethanediamine derivatives and preparation thereof
12/15/1998	US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998	US5849793 HIV matrix protein tyrosine position 29 pocket binders
12/15/1998	US5849784 Cyclic sulfone containing retroviral protease inhibitors
12/15/1998	US5849774 Treatment of sepsis-induced acute renal failure
12/15/1998	US5849752 Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
12/15/1998	US5849748 Therapeutic quassinoid preparations with antineoplastic antiviral, and herbistatic activity
12/15/1998	US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998	US5849714 Treatment of bacterial dysentery
12/15/1998	US5849709 Saccharopeptides and derivatives thereof
12/15/1998	US5849706 Method of treating retained asthma pulmonary secretions
12/15/1998	US5849696 Composition and method of treating hepatitis C
12/15/1998	US5849587 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
12/15/1998	US5849580 Nucleic acid encoding a NF-κB activation regulatory protein, IκBβ
12/15/1998	US5849575 Cloning and expression of host-protective immunogens of IBDV
12/15/1998	US5849533 Method for making unclipped HIV envelope protein
12/15/1998	US5849531 Compositions and treatments for pneumonia in animals
12/15/1998	US5849530 Manipulation of gene copy number in bordetella
12/15/1998	US5849482 Crosslinking oligonucleotides
12/15/1998	US5849476 Recombinant varicella-zoster virus and process for constructing same
12/15/1998	US5849299 Attenuated revertant serotype 1 marek's disease vaccine
12/15/1998	US5849295 Nucleotide sequences coding for a protein with urease activity
12/15/1998	US5849291 Opthalmic non-irritating iodine medicament
12/15/1998	CA2162186C Pradimicin derivatives
12/15/1998	CA2152541C Herpes ribonucleotide reductase inhibitors
12/15/1998	CA2092653C Substituted pyrrolidine derivatives as hiv protease inhibitors
12/15/1998	CA1340274C (1r,5s,6s)-2-substituted thio-6-¬(r)-1-hydroxy-ethyl\|-1-methyl-carbapenem-3-carboxylic acid derivatives
12/15/1998	CA1340273C 6-substituted thia-aza compounds
12/15/1998	CA1340215C Cc-1065 analogs having two cpi subunits
12/15/1998	CA1340213C Antigens of plasmodium falciparum
12/15/1998	CA1340184C Cloning and characterizing omega-interferon and related genes
12/13/1998	CA2240305A1 Process for the preparation of (1s,2r)-1-amino-2-indanol-(r,r)-tartrate methanol solvate
12/13/1998	CA2234424A1 Novel compounds
12/11/1998	CA2233584A1 7tm receptor hlwar77
12/11/1998	CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998	WO1998055646A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
12/10/1998	WO1998055640A1 Retroviral vector particles produced in a baculovirus expression system
12/10/1998	WO1998055627A1 Mutant measles virus antigens and genes encoding the same
12/10/1998	WO1998055624A1 Bacterial pheromones and uses therefor
12/10/1998	WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998	WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998	WO1998055604A1 Hydrophilic composition containing protease produced by vibrio
12/10/1998	WO1998055511A1 Novel canine cytokine protein
12/10/1998	WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998	WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
12/10/1998	WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998	WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998	WO1998055138A1 Pharmaceutical composition containing transfer factor for treatment of inflammatory bowel disease and regressive behavioural disorder
12/10/1998	WO1998055120A1 Anti-viral compounds
12/10/1998	WO1998055106A1 Method for preparing pharmaceutical formulation
12/10/1998	WO1998054981A1 Method for administering viable microorganism composition for poultry
12/10/1998	WO1998022575A3 Nucleotide sequence of escherichia coli pathogenicity islands
12/10/1998	CA2328503A1 Pharmaceutical composition containing transfer factor for treatment of inflammatory bowel disease and regressive behavioural disorder
12/10/1998	CA2293508A1 Anti-viral compounds
12/10/1998	CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998	CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998	CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998	CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/10/1998	CA2289491A1 Retroviral vector particles produced in a baculovirus expression system
12/10/1998	CA2262388A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
12/10/1998	CA2234423A1 Processes for preparation of marek's disease virus using continuous mammalian cell lines
12/09/1998	EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same
12/09/1998	EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998	EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998	EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998	EP0882448A1 Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
12/09/1998	EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization
12/09/1998	EP0882132A2 A human cytomegalovirus combined antigen and its use
12/09/1998	EP0882129A1 Recombinant expression of s-layer proteins
12/09/1998	EP0882063A2 Antifungic and antibacterial peptide
12/09/1998	EP0882058A1 Novel nucleoside derivatives and process for preparing the same
12/09/1998	EP0882052A1 New cephem compounds and pharmaceutical use thereof
12/09/1998	EP0882049A1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
12/09/1998	EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998	EP0882042A1 Antibiotic oxazolidinone derivatives
12/09/1998	EP0882041A1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
12/09/1998	EP0882024A1 Retroviral protease inhibiting compounds
12/09/1998	EP0882022A1 Aspartyl protease inhibitors
12/09/1998	EP0881900A1 Use of leukotriene b 4? or its analogues as antiviral and antineoplastic agents

1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 1798